Last reviewed · How we verify

Supraclavicular Block

Weill Medical College of Cornell University · FDA-approved active Small molecule

A supraclavicular block is a regional anesthesia technique that interrupts nerve conduction in the upper trunk of the brachial plexus by injecting local anesthetic near the supraclavicular fossa.

A supraclavicular block is a regional anesthesia technique that interrupts nerve conduction in the upper trunk of the brachial plexus by injecting local anesthetic near the supraclavicular fossa. Used for Anesthesia for upper extremity surgery (shoulder, arm, forearm, hand procedures), Postoperative pain management for upper extremity surgery.

At a glance

Generic nameSupraclavicular Block
SponsorWeill Medical College of Cornell University
ModalitySmall molecule
Therapeutic areaAnesthesiology
PhaseFDA-approved

Mechanism of action

This procedure involves the percutaneous injection of local anesthetic agents (such as lidocaine or bupivacaine) around the upper portion of the brachial plexus as it passes through the supraclavicular region. The anesthetic diffuses into nerve tissue, blocking sodium channels and preventing action potential propagation, thereby producing sensory and motor blockade of the upper extremity. This technique is used to provide anesthesia for surgical procedures on the shoulder, arm, and hand.

Approved indications

Common side effects

Key clinical trials

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

SourceUsed for
ClinicalTrials.govTrial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape: